Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction
- 30 April 2009
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 91 (4), 1526-1528
- https://doi.org/10.1016/j.fertnstert.2008.08.118
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndromeHuman Reproduction Update, 2008
- Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndromeHuman Reproduction, 2008
- Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation ratesFertility and Sterility, 2006
- GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSSReproductive BioMedicine Online, 2006
- Administration of Moderate and High Doses of Gonadotropins to Female Rats Increases Ovarian Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor-2 Expression that Is Associated to Vascular Hyperpermeability1Biology of Reproduction, 2003
- Vascular Endothelial Growth Factor Receptor-2 Activation Induces Vascular Permeability in Hyperstimulated Rats, and this Effect Is Prevented by Receptor BlockadeEndocrinology, 2002
- The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial growth factorFertility and Sterility, 1999
- Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndromeHuman Reproduction, 1998
- Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndromeThe Lancet, 1994
- Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatmentFertility and Sterility, 1992